Specifically, genetic variants, rs1521 and rs3094228, associated with Graves’ disease and TPOAb-positivity, alter the expression of thyroid cell-expressed ligands, MIC-A, MIC-B, and HLA-C, known to recognize CD314 and CD158b immunoreceptors expressed on NK cells. The gene discussed is KIR2DL3; the disease is Graves disease.